Estrella Immunopharma, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ESLA Nasdaq 2830 www.estrellabio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Estrella Immunopharma, Inc.

ESLA: Initiating Coverage of Estrella Immunopharma: A Potential Successor to Arcellx in Next-Generation CAR-T - Mar 18th, 2026 3:20 am
ESLA: 100% CR Rate in Phase 1/2 Trial of EB103 in Aggressive B Cell NHL - Feb 9th, 2026 7:02 am
Top 100 Stocks to Buy: Two Penny Stocks Moved Up 51 Spots. Should You Buy Either? - Nov 4th, 2025 10:13 am
Is Estrella Immunopharma (NASDAQ:ESLA) In A Good Position To Deliver On Growth Plans? - Aug 14th, 2025 4:36 am